HomeCSTL • NASDAQ
add
Castle Biosciences Inc
Previous close
$39.95
Day range
$39.13 - $39.97
Year range
$14.59 - $40.61
Market cap
1.14B USD
Avg Volume
466.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 83.04M | -3.19% |
Operating expense | 71.14M | 9.29% |
Net income | -501.00K | -122.08% |
Net profit margin | -0.60 | -122.64% |
Earnings per share | -0.02 | -125.00% |
EBITDA | -1.17M | -113.60% |
Effective tax rate | -29.79% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 287.54M | 2.77% |
Total assets | 562.79M | 9.37% |
Total liabilities | 95.74M | 30.24% |
Total equity | 467.05M | — |
Shares outstanding | 29.19M | — |
Price to book | 2.49 | — |
Return on assets | -3.07% | — |
Return on capital | -3.41% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -501.00K | -122.08% |
Cash from operations | 22.63M | -3.03% |
Cash from investing | -18.39M | -24.34% |
Cash from financing | -919.00K | -209.67% |
Net change in cash | 3.32M | -64.60% |
Free cash flow | -14.09M | -206.02% |
About
Founded
2007
Headquarters
Website
Employees
823
